European Commission approves first CAR T-cell therapiesAugust 28, 2018ALLPediatricsAggressive LymphomasB Cell Lymphoma
Meta-analysis supports rituximab maintenance in MCLAugust 16, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
Caution urged over real-world bleeding risk with ibrutinibAugust 14, 2018CLLAggressive LymphomasPatient & Survivor CareB Cell Lymphoma
Increased B-cell lymphoma risk with JAK1/2 inhibitorsAugust 8, 2018Myelodysplastic SyndromeAggressive LymphomasB Cell Lymphoma
PET/CT accurately predicts MCL stageAugust 2, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
Isavuconazole resolved invasive fungal disease in patients on ibrutinibJuly 29, 2018Aggressive LymphomasCLL
European Medicines Agency recommends CAR T-cell approvalsJune 29, 2018Mixed TopicsAggressive LymphomasB Cell Lymphoma
Bortezomib plus vorinostat shows modest response in MCLJune 29, 2018Mantle Cell LymphomaAggressive LymphomasB Cell Lymphoma
